Videos

ACG represents the first major in-person conference since the COVID-19 pandemic.

Dr. Feuerstadt presented data about RBX2660 during the recent ACG 2021 meeting.

An absence of urgency was associated with greater reductions in levels of inflammatory biomarkers C-reactive protein and fecal calprotectin in a cohort of patients treated with mirikizumab.

PROSE allows patients to report their symptoms of dysphagia in real-time.

Investigators found fistulizing Crohn’s disease increases the healthcare burden and lengthens the duration of hospital stays in patients with acute kidney injuries.

It can be challenging to find a suitable donor for fecal microbiota transplantation.

RBX2660 is a a standardized, stabilized, investigational microbiota-based live therapeutic being studied for the treatment of C difficile infections.

Patients with Crohn's disease often also suffer from kidney dysfunction.

Dr. Glanzman presented during AAP 2021 about executive function impairments in patients with ADHD.

Recent studies have shown the majority of potential FMT donors are ultimately rejected.

Executive function can include working memory, behavioral inhibition, and cognitive flexibility.

The retina field is equipped with ideal therapy and research informing implementation. Now it needs greater patient buy-in.

Rishi P. Singh, MD, discusses new VISTA/VIVID data showing what really influences a patients' likelihood and time to DME resolution when treated with aflibercept.

Theodore Leng, MD, MS, defines the trends of patient discontinuation, and how direct caregivers may help to reduce risk of losing patients.

Arshad Khanani, MD, MA, explains how new measures made available to ophthalmology will help address a quickly growing patient population.

Veeral S. Sheth, MD, MBA, discusses what ophthalmologists will need to learn about PDS application for patients with AMD.

Theodore Leng, MD, MS, discusses new findings based on IRIS registry data showing long-term discontinuation trends in patients.

An approval may be pending for the unique delivery system. An expert explains its benefit for nAMD patients and physicians alike.

Dr. Erickson discussed screening for children prone to sudden cardiac arrest and sudden cardiac death based on an updated AAP policy statement.

Dr. Michalsky discusses the utility of bariatric surgical options in patients with a high body mass index.

Dr. Carbone will present during AAP 2021 about managing autism in pediatric practices.

Dr. Fasipe shares her in-person experience viewing Phillip Okwo's Life Interrupted production about living with sickle cell disease.

Montefiore experts discuss the emphasis on education at their MFM-Cardiology care program.

An obstetrician-gynecologist and a cardiologist discuss the inception of their joint cardiovascular care program for expecting mothers.

Dr. Castro considers it to be a fruitful and exciting time in the study of asthma-modifying therapy, with some biologic therapies achieving control in patients with severe asthma.

Dr. Castro talks of the available biologic therapies that can be used to treat asthma and other respiratory disorders.

The TMIOA Medical Director and Principal Investigator discusses the idea behind hosting a mixed in-person and virtual conference for this year's Heart in Diabetes.

Dr. Ezhkova and fellow investigators found that low UV exposure prompted an increase in pigmentation production through melanocytes in the body.